Sodium laureth sulfate (INCI: Sodium Laureth Sulfate, often shortened to SLES) is an anionic surfactant. A lauryl alcohol is ethoxylated, then sulfated, and the salt is the sodium salt. It cleans and builds foam, mostly in products that are rinsed off. The CIR Expert Panel’s amended assessment, published in 2010, concluded that sodium laureth sulfate and the other salts of sulfated ethoxylated alcohols named in that assessment are safe as cosmetic ingredients in the present practices of use and concentration when formulated to be non-irritating.
Sodium laureth sulfate is the sodium salt of a sulfated ethoxylated lauryl alcohol. “Laureth” is the INCI mark of that ethoxylation: ethylene oxide is added to the fatty alcohol before the sulfate group goes on. The chain length of the alcohol and the number of ethylene oxide units are an average, not a single molecule, in most commercial supplies. CosIng ref. 79583 describes one structure in words, sodium 2-(2-dodecyloxyethoxy)ethyl sulphate, and that description matches CAS 3088-31-1 and EC 221-416-0, the 2-mole ethoxylate. The same inventory row also prints other CAS and EC numbers. Other CAS numbers associated with this INCI may represent different or broader chemical identities. Some are generic CAS numbers that can encompass overlapping ethoxylate distributions. Hazard classifications should therefore be interpreted according to their specific registered identities rather than combined indiscriminately.
On a label it is a cleansing surfactant. It lowers the surface tension of water so oil and soil can be lifted, and it helps a wash foam. CosIng lists the functions cleansing, emulsifying, foaming, and surfactant. Those words describe a job in the formula. They are not a claim that the ingredient treats a skin disease. The ingredient index records the functions surfactant and emulsifier for this name. It is not marked as a fragrance, a preservative, or a colourant, and it is not one of the fragrance substances that Annex III requires to be named above a set concentration.
Robinson and colleagues (International Journal of Toxicology, 2010) is the published form of the CIR final amended report. The Panel concluded that sodium laureth sulfate, ammonium laureth sulfate, and the other salts of sulfated ethoxylated alcohols named in the conclusion are safe as cosmetic ingredients in the present practices of use and concentration described in the assessment when formulated to be non-irritating. The scope is that list of salts and those practices of use. In the 2007 FDA Voluntary Cosmetic Registration Program figures quoted in the report, sodium laureth sulfate had 2,180 uses. Shampoos accounted for 745 of those uses, in a shampoo category the table lists as 1,022 products, and bath soaps and detergents accounted for 512, in a category listed as 594. A 2008 survey by the Personal Care Products Council, quoted in the same report, gave this ingredient a range of 0.1% to 50%: shampoos 11% to 50%, bath soaps and detergents 2% to 47%, skin cleansers 0.6% to 25%, and moisturisers 0.5% across 6 uses. Those percentages are shares of the finished product in that survey. They are not a legal maximum, and they are not the concentration in a reader’s bottle. That 2008 survey is a Council survey. The industry support for the CIR is stated with the conclusion below.
Its job is to lift oil and soil into the rinse water. Shampoos, body washes, and face cleansers are where the 2007 use figures concentrate. A place near the top of an INCI list is consistent with a large share of the formula. It does not, by itself, show the percentage.
The sulfate head and the ethoxylated tail help a wash foam. Foam is a feel people often read as cleaning. The amount of foam is not a measure of how irritating the wash is, and it is not a measure of how clean the skin is afterwards.
Sodium lauryl sulfate (SLS) is the same sort of anionic sulfate without the ethoxylation step. The molecule of SLES is larger. In irritant patch tests, the reaction to SLES has been milder than the reaction to SLS at the same test concentration. That comparison is set out below. It is a comparison of those tests, not a promise about every formula.
The same CIR table records leave-on uses, including 6 moisturiser uses at 0.5% and 18 mascara uses at 0.1% to 0.3% in the 2008 survey. A rinse-off shampoo and a mascara are not the same exposure. The CIR condition is the same for both: formulated to be non-irritating, within the uses and concentrations in that assessment.
A different INCI is a different count. Sodium laureth-12 sulfate, sodium laureth-40 sulfate, and ammonium laureth sulfate are not this ingredient. The product section gives the count for this name only.
These three names are easy to fold together. They are not the same substance, and they are not counted together.
Sodium laureth-12 sulfate has a specific CAS identity of 66161-57-7 (Health Canada’s ingredient entry for that name). The broader CAS 9004-82-4 is also associated with this ingredient but is not exclusive to the 12-ethoxy-unit form. Japanese cosmetic-ingredient labelling for sodium laureth-12 sulfate lists 66161-57-7 and marks 9004-82-4 as generic.
Ethoxylation is the step SLS does not have. It is also the step that can leave 1,4-dioxane as a manufacturing impurity. 1,4-Dioxane is not an ingredient that is added for a cosmetic job. The regulatory section sets out Annex II and Article 17. Löffler and Happle, in Contact Dermatitis in 2003, patched SLS and SLES at 0.125%, 0.25%, 0.5%, 1.0%, and 2.0% for 6, 12, or 24 hours, and read transepidermal water loss and blood flow. They described a pronounced reaction to SLS and a far milder one to SLES. Increased water loss from SLS was still measurable at day 10 at every concentration they tested. The SLES reaction, on their reading, was convincingly detectable only up to day 7. Their abstract does not state how many people were tested. That study is an irritant patch under occlusion. It is not a wash-off shower, and it is not a test for contact allergy. It was published in 2003, before the 2010 CIR report.
| Sodium laureth sulfate | Sodium lauryl sulfate | Sodium laureth-12 sulfate | |
|---|---|---|---|
| What it is | An ethoxylated lauryl sulfate, sodium salt. The 2-mole substance is CAS 3088-31-1. | An alkyl sulfate with no ethoxy units. SLS, CAS 151-21-3. | A named degree of ethoxylation, about 12 moles. A different INCI. Specific CAS 66161-57-7. The broader CAS 9004-82-4 is also associated with this ingredient but is not exclusive to the 12-ethoxy-unit form. |
| 2010 CIR group | Named in the conclusion: safe in the practices of use and concentration in the assessment when formulated to be non-irritating. | Not part of that salt group. The SLS page carries the assessment for SLS. | Not the INCI “sodium laureth sulfate”. Ammonium laureth sulfate is in the 2010 group. A stated “-12” salt is a different name. |
| 1,4-Dioxane | Ethoxylation can leave this impurity. It is a separate substance, prohibited in Annex II, with a narrow trace rule in Article 17. | No ethoxylation step, so this particular impurity is not the question for SLS. | Also ethoxylated, so the same impurity question can apply. It is still a different ingredient. |
CosIng ref. 79583, in the inventory extract dated 4 October 2012, lists sodium laureth sulfate with the functions cleansing, emulsifying, foaming, and surfactant, and it prints several CAS numbers on one row, including 3088-31-1, 9004-82-4, 68891-38-3, 1335-72-4, 68585-34-2, and 91648-56-5. Inclusion in CosIng is not an authorisation. Cosmetic ingredient use in the EU is primarily governed by Regulation (EC) No 1223/2009 and its Annexes, alongside other applicable EU chemicals legislation. That inventory row carries no Annex reference. This page does not turn the absence of a reference on an inventory row into a claim that every use is unrestricted. The legal texts below are the ones checked.
1,4-Dioxane is a different substance. Annex II entry 343 of Regulation (EC) No 1223/2009 lists Dioxane, CAS 123-91-1, EC 204-661-8, among the substances prohibited in cosmetic products. Article 17 allows the non-intended presence of a small quantity of a prohibited substance, stemming from impurities of natural or synthetic ingredients, the manufacturing process, storage, or migration from packaging, which is technically unavoidable in good manufacturing practice, provided that presence is in conformity with Article 3. Article 3 requires the finished product to be safe for human health. Article 17 is a trace rule. It is not a permission to add 1,4-dioxane as an ingredient.
SCCS/1570/15, adopted on 15 December 2015, is the committee’s opinion on an ICCR report about traces of 1,4-dioxane. The conclusion is that trace levels representing a lifetime cancer risk of 10−5 or lower are considered safe for the consumer, and thus a trace level of 10 ppm or lower in cosmetic products is safe, and that a target level of 10 ppm or lower in finished cosmetic products should be phased in over a short transition period. The request to the committee records that the ICCR documents have no regulatory status. The 10 ppm figure is the committee’s scientific target for the impurity in a finished product. It is not an Annex limit, and it is not a measurement of any one bottle. This opinion is later than the 2010 CIR review. It is not part of that review. Finished cosmetics are regulated by Regulation (EC) No 1223/2009. CLP classification of a raw material does not apply to the finished cosmetic.
A label that says “sulfate-free” is a claim about what the formula leaves out. The technical document on cosmetic claims agreed by the Sub-Working Group on Claims on 3 July 2017 says, under the fairness criterion, that “free from” claims or claims with a similar meaning should not be allowed when they imply a denigrating message, notably when they are mainly based on a presumed negative perception of the safety of an ingredient that is used in accordance with the Regulation. The examples named there are certain parabens, phenoxyethanol, and triclosan. The document does not name sulfates. It is guidance on the common criteria. It is not a judgment of a court, and it does not by itself ban the words on a bottle.
The CIR amended assessment published in 2010 concluded that sodium laureth sulfate is one of a named group of salts of sulfated ethoxylated alcohols that are safe as cosmetic ingredients in the practices of use and concentration described in that assessment, when formulated to be non-irritating. The abstract of that report says sodium laureth sulfate was shown to be a dermal and ocular irritant but not a sensitizer, in the testing the panel was summarising. “Not a sensitizer” there is a summary of those tests. It is not a finding that no person can develop contact allergy, and it is not a description of an irritant reaction.
For most consumers, SLES can be used safely in appropriately formulated rinse-off cosmetics. However, it can irritate the skin and eyes, particularly under more concentrated or prolonged exposure. Its presence on an ingredient list alone does not establish whether a finished product will be irritating.
The final amended report (published 2010) is the current CIR conclusion for this group. Sodium laureth sulfate is named in it. The conclusion is safe as cosmetic ingredients in the present practices of use and concentration when formulated to be non-irritating. The 2,180 VCRP uses in 2007, of which 745 are shampoos and 512 are bath soaps and detergents, are the frequency scope the report gives for this ingredient. The 2008 Council survey range for it is 0.1% to 50%. A short label sometimes placed next to a CIR conclusion, such as “safe as used”, points at this text. It is not the number in the rating section.
The Cosmetic Ingredient Review is supported by the cosmetics industry through the Personal Care Products Council. The 2008 concentration survey quoted in the report is a Council survey.
Environment and Climate Change Canada and Health Canada published the final screening assessment of the Poly(alkoxylates/ethers) Group in November 2022 (assessment text). It covers three alcohol ethoxylate sulfates, including CAS 9004-82-4, CAS 68585-34-2, and CAS 67762-19-0. For human health, exposure was assessed as high and the hazard as low, and the assessment concluded that exposure is unlikely to pose a human health risk to the general population at the uses and exposures considered. Separately, those three substances are not expected to result in ecological concern on the information in the assessment. The assessment is not specific to CAS 3088-31-1, and it does not replace the classifications reported for that CAS. It is a government assessment, set beside the industry-funded CIR conclusion above. Read 20 November 2026.
The 2010 CIR conclusion applies to the cosmetic uses and concentrations that assessment described, when the formula is non-irritating. The studies cited on this page do not quantify a risk that is specific to pregnancy or to breastfeeding. Someone who is pregnant or nursing and wants advice about a specific product should ask their own clinician.
The fixed list is a predefined set of common ingredient names. Each name on it is given a set score, and the score applies only to those names. This 4/10 rating is a predefined score from our fixed list of common ingredient names, not a hazard classification derived from the GHS evidence presented below. It should not be interpreted as a scientifically calibrated measure of safety or risk. It is separate from the CIR conclusion. How this number is set.
Irritation, contact sensitisation, and immediate hypersensitivity are not the same event. Irritation is damage or inflammation that can happen on first contact and that tends to rise with concentration and with time on the skin. Contact sensitisation is an allergy of the delayed type. A positive patch test, read for allergy, is evidence about that second event. It is not, by itself, a reaction every time that person uses a finished wash. Immediate hypersensitivity, of the kind that can follow some drugs within minutes, is a third event. The irritant-patch studies below do not measure it.
Turkoglu, Pekmezci, and Sakr (International Journal of Cosmetic Science, 1999) applied SLES, alone and in mixtures, to 13 people under a 24-hour occlusive patch. At 2 mg per patch, 10 of the 13 showed no skin reaction. At 20 mg per patch, 11 of the 13 showed a range of irritation. The authors reported that irritation depended on the dose, and that the highest irritation in their set was the mixture of SLES, lauryl glucoside, and cocamide DEA. That is an occlusive patch of the raw surfactant system. It is not a two-minute shower, and the score is an irritation score, not a diagnosis of contact allergy. The study was published in 1999, before the 2010 CIR report.
Löffler and Happle (Contact Dermatitis, 2003) compared SLS, SLES, and an alkyl polyglucoside in irritant patches, as described in the comparison above. They called the SLES reaction far milder than the SLS reaction in that design. The abstract does not give the number of volunteers, so this page does not invent one. A milder irritant patch is still an irritant finding. It does not show that a leave-on product at the top of the 2008 survey range is bland, and it does not measure contact allergy.
The CIR assessment reported no sensitisation in the studies reviewed. Separately, some company classifications for CAS 3088-31-1 include H317. These findings differ in scope and evidentiary basis and should not be interpreted as directly equivalent. The notification percentages do not establish the incidence of allergy among cosmetic users.
No harmonised classification entry in CLP Annex VI as amended up to ATP22 (Commission Delegated Regulation (EU) 2024/2564, applicable from 1 May 2026). ATP23 (Commission Delegated Regulation (EU) 2025/1222, published in the Official Journal on 20 June 2025, applicable from 1 February 2027) was also checked. Read 20 November 2026. Each CAS was searched on its own: 3088-31-1, 9004-82-4, 68585-34-2, 66161-57-7, 68891-38-3, 1335-72-4, and 91648-56-5. None is in the Annex VI table through ATP21, and none is inserted or replaced by ATP22 or ATP23. This check is not a statement about company notifications.
PubChem CID 23682204 is sodium 2-(2-dodecyloxyethoxy)ethyl sulfate, EINECS 221-416-0, the substance behind CAS 3088-31-1. On 20 November 2026 its GHS section showed an ECHA C&L aggregation for that identity: 284 company reports from 9 notifications. Of those reports, 4 of 284 were reported as not meeting GHS hazard criteria. Among reports that carry hazard codes, the codes shown above 10% were H315 (98.2%), H317 (54.9%), H318 (45.1%), and H319 (40.8%). PubChem states that this aggregation shows only codes above 10%. Those percentages are shares of the company reports. They are not the share of people who react, and they are not a concentration in a product. H302 is not in that above-10% list. This aggregation is not an EU harmonised classification under CLP Annex VI. Notifications for EC 500-234-8 (CAS 68891-38-3, alcohols C12–14, ethoxylated 1–2.5 moles, sulfated, sodium salts) are for that registered identity. That CAS is generic and can overlap other ethoxylate distributions, so those notifications are not combined into these 284 reports.
m-nite-9004-82-4e is the NITE page for generic CAS 9004-82-4, not the 12-ethoxy-unit CAS 66161-57-7. The substance name on that page is sodium alpha-dodecan-1-yl-omega-(sulfonatooxy)poly(oxyethylene), classification year FY2008. The NITE integrated list, read the same day, includes CAS 9004-82-4 and does not list CAS 3088-31-1, CAS 66161-57-7, or CAS 68891-38-3. The page is not the classification of those other identities. For human health, and not as a CLP Annex VI entry, acute oral toxicity is Category 4, H302, from a rat oral LD50 of 1,600 mg/kg cited to RTECS (1999). Skin corrosion/irritation is Category 2, H315. Serious eye damage/eye irritation is Category 2, H319. Skin sensitisation is recorded as classification not possible, for lack of data. Specific target organ toxicity, single exposure, is Category 2 for the gastrointestinal system, H371. Aspiration hazard is Category 1, H304. The environmental classes are separate. Short-term aquatic hazard is Category 2, H401, from a 48-hour EC50 of 3.12 mg/L in Ceriodaphnia cited to AQUIRE (2008). Long-term aquatic hazard is Category 2, H411. NITE states that a government classification is a reference for labels and safety data sheets and is not mandatory to copy onto a Japanese label.
A separate block on the same PubChem page, attributed to the Safe Work Australia Hazardous Chemical Information System for CAS 3088-31-1, lists H302, H315, and H319. That block matches the CAS. It is not the NITE page, and it is not the ECHA aggregation above.
Which CAS the notifications belong to: Commercial bottles often use the INCI name while the raw material is the C12–14 ether sulfate, CAS 68891-38-3, EC 500-234-8, ethoxylated about 1 to 2.5 moles. That CAS is generic and can overlap other ethoxylate distributions, so it is not treated as the same registered identity as CAS 3088-31-1. The ECHA percentages on this page are only the 284 reports for EC 221-416-0. The NITE classifications on this page are only generic CAS 9004-82-4, not CAS 66161-57-7. Hazard classifications should be read for the identity each source names, rather than combined indiscriminately.
Rinse-off and leave-on: In the 2007 VCRP figures in the CIR report, shampoo and bath soap dominate the uses. The same report’s 2008 survey still records leave-on categories, including moisturisers at 0.5% and mascara at 0.1% to 0.3%. The panel’s condition, formulated to be non-irritating, applies to the uses it assessed, including those leave-on uses. A short contact in the shower is a smaller exposure than a product that stays on the skin, at the same concentration.
Look for the INCI name Sodium Laureth Sulfate. SLES is the short name, not a different ingredient. Sodium Lauryl Sulfate is the non-ethoxylated sulfate, and it has its own page. Labels may also show 月桂醇聚醚硫酸酯鈉, 月桂醇聚醚硫酸酯钠, ラウレス硫酸Na, or 소듐라우레스설페이트. A position in the list does not reveal the percentage. Under Regulation (EC) No 1223/2009, Article 19(1)(g), ingredients below 1% may be listed in any order after those at or above 1%.
A humectant often listed in the same shampoo or wash. It does not cancel the surfactant, and it is not a substitute for formulating the wash so that it does not irritate.
An amphoteric surfactant often paired with SLES in a wash. It is a different chemical class. This page does not transfer the CIR conclusion for the ethoxylated sulfates onto that betaine.
SLS has no ethoxy units. Irritant patches have shown a stronger reaction to SLS than to SLES at the same test concentration. The two names are not interchangeable on a label.
The “-12” is a stated average of about 12 ethoxy units, and it is its own INCI. On 20 November 2026 the product index counted 163 products for that name, 4 for sodium laureth-40 sulfate, and 150 for ammonium laureth sulfate. Those counts are not part of the count for sodium laureth sulfate.
On 20 November 2026, 4,411 products in the SkinSenseDiary product index list sodium laureth sulfate. A product is counted once. The count is a usage figure for this index, not evidence of safety. Each of those products had a category. The most common were shampoo (1,256), body wash (689), cleanser (620), bath (204), and conditioner (183). Examples from that index: